ELVN
Enliven Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD51.73
+0.89 (+1.74%)
Rating:C
Company Profile
CEO
Richard A. Fair
IPO Date
2020-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$51.49
Prev. Close
$50.85
Day Low
$50.48
Day High
$52.00
52W Low
$14.79
52W High
$52.00
Market Cap
$3.70B
Volume
0.16M